ALDH7A1 and neoplasm: Given that efficacy studies are often the first PDE experiments with any given drug, and evidence of significant drug efficacy is typically a gateway to further evaluation into mechanism, resistance, biomarker development and selection for clinical trials, having high confidence in these initial tumor responses is critical.